Society for NeuroOncology Annual Meeting
PCV Chemotherapy Plus RT Improves OS, PFS in Low-Grade Glioma
November 15th 2014The combination of radiation therapy and procarbazine, CCNU, and vincristine (PCV) prolonged both overall survival (OS) and progression-free survival (PFS) compared with radiation therapy (RT) alone in a phase III study of patients with grade 2 glioma.
Read More
